Multiple sclerosis other diagnostic studies

Jump to: navigation, search

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis other diagnostic studies

CDC on Multiple sclerosis other diagnostic studies

Multiple sclerosis other diagnostic studies in the news

Blogs on Multiple sclerosis other diagnostic studies

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

visual evoked potential studies, antimyelin antibodies, and optimal coherence tomography may be helpful in the diagnosis of multiple sclerosis.

Other Diagnostic Studies

Other diagnostic studies for Multiple sclerosis disease include:

  • Optimal coherence tomography: Optimal coherence tomography of the retina can be helpful in diagnosis of multiple sclerosis.[8]

References

  1. Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, O'Day J, Grigg J, Billson F, Yiannikas C (September 2008). "Axonal loss and myelin in early ON loss in postacute optic neuritis". Ann. Neurol. 64 (3): 325–31. doi:10.1002/ana.21474. PMID 18825673.
  2. Chiappa KH (November 1988). "Use of evoked potentials for diagnosis of multiple sclerosis". Neurol Clin. 6 (4): 861–80. PMID 3070342.
  3. Matthews WB, Wattam-Bell JR, Pountney E (April 1982). "Evoked potentials in the diagnosis of multiple sclerosis: a follow up study". J. Neurol. Neurosurg. Psychiatry. 45 (4): 303–7. PMC 491364. PMID 7077339.
  4. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M (July 2003). "Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event". N. Engl. J. Med. 349 (2): 139–45. doi:10.1056/NEJMoa022328. PMID 12853586.
  5. Gaertner S, de Graaf KL, Greve B, Weissert R (December 2004). "Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis". Neurology. 63 (12): 2381–3. PMID 15623705.
  6. Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R (January 2007). "Lack of association between antimyelin antibodies and progression to multiple sclerosis". N. Engl. J. Med. 356 (4): 371–8. doi:10.1056/NEJMoa063602. PMID 17251533.
  7. Lampasona V, Franciotta D, Furlan R, Zanaboni S, Fazio R, Bonifacio E, Comi G, Martino G (June 2004). "Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects". Neurology. 62 (11): 2092–4. PMID 15184621.
  8. Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A (November 2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". J. Neurol. 254 (11): 1595–6. doi:10.1007/s00415-007-0538-3. PMID 17987252.



Linked-in.jpg